Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Marketing...

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Jun 09, 2021 10:38am

143 Views

Post# 33354732

RE:Marketing...

almost like they don't know how to run company?

MasterAlgae wrote:

I think Antibe needs to update its marketing and news-release material under the section: About Antibe Therapeutics Inc.
The company spent many months and undoubtedly 1000s of dollars to amalgamate so that effort should be reflected in the 'About Us' section of all news releases. It needs to (and should already be) reflect that it owns a strong intellectual property portfolio and has (X number of) patents granted and (X number) of patents pending around the world.

For example:

About Antibe Therapeutics Inc.

Antibe is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to address inflammation arising from a wide range of medical conditions. Antibe holds a strong intellectual property portfolio with (x number) of patents granted and (x number) of patents pending around the world. The Company’s current pipeline includes....etc etc